Tag:
Cinryze
Latest Headlines
Latest Headlines
ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion
With an investor call looming, ViroPharma ( $VPHM ) and its partner are responding quickly to the FDA's rejection of production expansion plans for its drug Cinryze, manufactured in the...
ViroPharma aims to double manufacturing capacity
Parallel chromatography is ViroPharma's current hero. Cheered by the success of parallel chromatography in turning out its injectable drug Cinryze , the company has now asked FDA for permission to
Lev Pharma wins FDA approval for Cinryze
Lev Pharmaceuticals has won FDA approval to market Cinryze to treat hereditary angioedema, a potentially lethal genetic disorder characterized by a swelling of the hands, feet or some other body
ViroPharma to buy Lev for $442M
ViroPharma has forged a deal to buy Lev Pharmaceuticals - a developer focused on developing inflammatory therapies -- for $442 million. The deal provides ViroPharma with Lev's Cinryze program, a
